| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9c73b81f32b8be45a1ea5cb361997fc0 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-414
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-252 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-507
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-58 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L33-06 |
| filingDate |
2012-11-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2014-01-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_814a0e5cd8d774fd2790df7c6d8c2a9e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8cf74fdcf74f2ac0872472971a9a615b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_38dc75fc8bb2b9baf5cfc213336a7ade
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_05edec4fc862f37567148a8ce7885e05 |
| publicationDate |
2014-01-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
RU-2504406-C1 |
| titleOfInvention |
Method for making bioresorbed small-diameter hybrid vascular graft |
| abstract |
FIELD: medicine. n SUBSTANCE: invention refers to medicine and tissue engineering, and may be used in cardiovascular surgery for small-vessel bypasses. A vascular graft is made by two-phase electrospinning with the staged introduction of the ingredients into the polymer composition. n EFFECT: making the bioresorbed small-diameter vascular graft possessing the improved biocompatibility ensured by using the polymer composition of polyhydroxybutyrate (PHBV) with oxyvalerate, and epsilon-polycaprolactone with type IV collagen, human fibronectin and human fibroblast growth factor (hFGF) additionally introduced into the composition. n 2 cl, 1 ex |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2622986-C2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2630061-C1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2642259-C2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103961750-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2660550-C1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2572333-C1 |
| priorityDate |
2012-11-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |